AI-generated summary
This review summarizes laboratory, animal and clinical studies of ultra-low-level laser therapy using 633 or 670 nm light at very low power densities. The authors report neural cell benefits, anti-edema and anti-hyperalgesia effects in rats, and beneficial clinical findings for musculoskeletal disorders, and they note the underlying biophysical mechanisms remain unclear.
- Who or what was studied
- unclear
- Wavelengths
- 633, 670 nm
- Limits stated in the abstract
- The abstract describes a narrative review of cell, animal and clinical evidence without stating the number of studies or participants, and it notes the biophysical mechanisms are unresolved.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 670 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Oxidative stress. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.